^a Tested in dextrose 5%.

^b Tested in sodium chloride 0.9%.

^c Tested in both dextrose 5% and sodium chloride 0.9%.

^d Tested in dextrose 5% with albumin human 2 mg/mL.

^e Lyophilized formulation tested.

^f Refer to Appendix for the composition of parenteral nutrition solutions. TNA indicates a 3-in-1 admixture, and TPN indicates a 2-in-1 admixture.

^g Injected via Y-site into an administration set running azithromycin.

^h Imipenem component. Imipenem in a 1:1 fixed-ratio concentration with cilastatin.

ⁱ Not specified whether concentration refers to single component or combined components.

^j Quinupristin and dalfopristin components combined.

^k Salt not specified.

^l Ceftolozane component. Ceftolozane in a 2:1 fixed-ratio concentration with tazobactam.

^m Meropenem component. Meropenem in a 1:1 fixed-ratio concentration with vaborbactam.

ⁿ Ceftazidime component. Ceftazidime in a 4:1 fixed-ratio concentration with avibactam.

^o Tested in dextrose 5%, sodium chloride 0.9%, and Ringer’s injection, lactated.

^p Test performed using the formulation WITH edetate disodium.

^q Run at 25 mL/hr with dextrose 5% run at 83 mL/hr.

^r Run at 100 mL/hr.

^s Sulbactam component. Sulbactam in a 1:1 fixed-ratio concentration with durlobactam.